ArticleDiabetes, obesity & metabolism2026

Efficacy and safety of switching to ezetimibe 10 mg/rosuvastatin 2.5 mg in Korean patients with type 2 diabetes mellitus and dyslipidaemia: A multicentre, prospective study (EROICA study).

Sangmo Hong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.